TR200802061A2 - Yüksek oranda aktif madde içeren farmasötlk formülasyon. - Google Patents

Yüksek oranda aktif madde içeren farmasötlk formülasyon.

Info

Publication number
TR200802061A2
TR200802061A2 TR2008/02061A TR200802061A TR200802061A2 TR 200802061 A2 TR200802061 A2 TR 200802061A2 TR 2008/02061 A TR2008/02061 A TR 2008/02061A TR 200802061 A TR200802061 A TR 200802061A TR 200802061 A2 TR200802061 A2 TR 200802061A2
Authority
TR
Turkey
Prior art keywords
active ingredient
pharmaceutical formulation
formulation containing
highly active
containing highly
Prior art date
Application number
TR2008/02061A
Other languages
English (en)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2008/02061A priority Critical patent/TR200802061A2/tr
Publication of TR200802061A2 publication Critical patent/TR200802061A2/tr

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş, oral uygulama için aktif madde olarak Bileşik I'yi veya bunun farmasötik olarak kabul edilebilir bir tuzunu veya hidratını veya hidratının tuzunu, ağırlıkça % 80 oranı üzerinde içeren farmasötik preparat ile ilgilidir.
TR2008/02061A 2008-03-27 2008-03-27 Yüksek oranda aktif madde içeren farmasötlk formülasyon. TR200802061A2 (tr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2008/02061A TR200802061A2 (tr) 2008-03-27 2008-03-27 Yüksek oranda aktif madde içeren farmasötlk formülasyon.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2008/02061A TR200802061A2 (tr) 2008-03-27 2008-03-27 Yüksek oranda aktif madde içeren farmasötlk formülasyon.

Publications (1)

Publication Number Publication Date
TR200802061A2 true TR200802061A2 (tr) 2009-07-21

Family

ID=42791568

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2008/02061A TR200802061A2 (tr) 2008-03-27 2008-03-27 Yüksek oranda aktif madde içeren farmasötlk formülasyon.

Country Status (1)

Country Link
TR (1) TR200802061A2 (tr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013077815A1 (en) 2011-11-24 2013-05-30 Ak Farma İlaç Sanayi Ve Ticaret A.Ş. Imatinib solid dosage forms reconstituted just before use
WO2021009686A1 (en) 2019-07-15 2021-01-21 Intas Pharmaceuticals Ltd. Pharmaceutical composition of imatinib

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013077815A1 (en) 2011-11-24 2013-05-30 Ak Farma İlaç Sanayi Ve Ticaret A.Ş. Imatinib solid dosage forms reconstituted just before use
WO2021009686A1 (en) 2019-07-15 2021-01-21 Intas Pharmaceuticals Ltd. Pharmaceutical composition of imatinib

Similar Documents

Publication Publication Date Title
UA109421C2 (uk) Фармацевтична композиція, яка містить ліганди сигма-рецептора
UA105229C2 (uk) Фармацевтичний склад
MX354102B (es) Derivados de bencimidazol-prolina.
MY151295A (en) Pyrimidyl indoline compound
NO20072978L (no) Nye betuinderivater, preparat derav og anvendelse derav
WO2010136474A3 (en) Substituted aminobutyric derivatives as neprilysin inhibitors
HK1149258A1 (en) Compounds
TN2013000257A1 (en) Immunosuppressant formulations
NZ702826A (en) Oral formulations and lipophilic salts of methylnaltrexone
EA201071094A1 (ru) Тризамещенные 1,2,4-триазолы в качестве модуляторов никотиновых ацетилхолиновых рецепторов
TW200626158A (en) Naphthaline derivatives
NO20043367L (no) Oralt farmasoytisk preparat
GEP20135744B (en) Quinuclidine carbonate derivatives and medicinal compositions containing the same
MX345544B (es) Derivados de triazol como ligandos para receptores de acido gamma-aminobutirico (gaba).
MY161749A (en) Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use
MA32406B1 (fr) Composés contenant de l'azote tricyclique et utilisation de ceux-ci comme antibactériens
TR200802061A2 (tr) Yüksek oranda aktif madde içeren farmasötlk formülasyon.
MA32722B1 (fr) Formulation galénique renfermant de l'aliskirène et procédé associé de préparation par granulation par fusion-extrusion
MX342824B (es) Nuevos compuestos de triazol iii.
WO2008148710A3 (en) Aryloxazole, aryloxadiazole and benzimidazole derivatives as modulators of somatostatins receptor activity
TW200738703A (en) 2-Carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
WO2012153347A3 (en) Oral pharmaceutical composition of olanzapine form 1 and sodium starch glycolate
WO2010131192A3 (en) Novel oxazolidinone derivatives and their use as orexin receptor antagonists
WO2008022242A3 (en) Synthesis of propyl phenoxy ethers and use as delivery agents
TH136433A (th) สูตรผสมและเกลือลิพอฟิลิคของเมทิลแนลเทร็กโซนที่ให้ทางปาก